Bausch + Lomb enVista
Case Details:
Bausch & Lomb Recalled Implantable Eye Lenses
On March 27, 2025, Bausch & Lomb recalled certain intraocular lenses following patients’ reports of eye damage that could potentially lead to vision loss. The voluntary recall was announced after the company received reports of complications that could not be immediately explained.
The recall affects enVista Aspire, enVista Envy, and some enVista monofocal lenses in the U.S. These artificial lenses are implanted in the eye to improve vision following cataract surgery.
Bausch & Lomb reported an increased number of cases of toxic anterior segment syndrome (“TASS”) from patients of these lenses. TASS is an inflammatory reaction caused by toxic substances entering the eye, leading to symptoms such as redness, swelling, pain, clouding of the eye, and pupil abnormalities. In severe cases, TASS can cause increased fluid pressure within the eye, potentially leading to secondary glaucoma and permanent damage to the cornea.
Severe cases of TASS may result in glaucoma or vision loss.
What’s Next?
If you believe you or a loved one may have been affected by this recall or have any concerns, please contact the BG&G legal team to discuss joining a class action.
Please also contact your eye care provider.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents consumers in class action and mass torts cases, and investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for consumers and investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.